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CD4+ T-helper (Th) cells reactive against myelin antigens mediate the mouse model
experimental autoimmune encephalomyelitis (EAE) and have been implicated in the
pathogenesis of multiple sclerosis (MS). It is currently debated whether encephalitogenic
Th cells are heterogeneous or arise from a single lineage. In the current study, we chal-
lenge the dogma that stimulation with the monokine IL-23 is universally required for
the acquisition of pathogenic properties by myelin-reactive T cells. We show that IL-12-
modulated Th1 cells readily produce IFN-γ and GM-CSF in the CNS of mice and induce a
severe form of EAE via an IL-23-independent pathway. Th1-mediated EAE is character-
ized by monocyte-rich CNS infiltrates, elicits a strong proinflammatory cytokine response
in the CNS, and is partially CCR2 dependent. Conversely, IL-23-modulated, stable Th17
cells induce EAE with a relatively mild course via an IL-12-independent pathway. These
data provide definitive evidence that autoimmune disease can be driven by distinct CD4+
T-helper-cell subsets and polarizing factors.
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Introduction
Multiple sclerosis (MS), an inflammatory demyelinating disease of
the CNS, is believed to be autoimmune in etiology. In the animal
model experimental autoimmune encephalomyelitis (EAE), active
immunization with MHC Class II-restricted epitopes of myelin pro-
teins or adoptive transfer of myelin-reactive CD4+ T cells results
in an ascending paralysis with histopathological features that are
reminiscent of MS. However, EAE studies have shown that not
all myelin-reactive T cells are pathogenic [1–3]. A major goal in
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MS research is to elucidate the factors required for the differentia-
tion and function of encephalitogenic T cells that might ultimately
serve as biomarkers or novel therapeutic targets in the clinical
setting.
It is widely believed that exposure of myelin-reactive T cells to
the cytokine IL-23 is critical for their acquisition of pathogenic
properties [1, 4, 5]. IL-23 promotes the expansion of IL-17-
producing Th17 cells [4, 5]. Interestingly, “hallmark” Th17
cytokines (including IL-17A and IL-17F) are dispensable for the
development of EAE [6]. Several recent studies suggest that the
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mechanism of action of IL-23 in EAE is to induce the production
of GM-CSF, which drives the accumulation of pro-inflammatory
myeloid cells in the CNS, culminating in axonopathy and demyeli-
nation [7, 8]. In contrast to the relationship between IL-23
and GM-CSF in mice, GM-CSF production is associated with the
IL-12/Th1 axis in humans, including individuals with MS [9].
IL-12-polarized, IFN-γ-producing Th1 cells were once thought to
be critical autoimmune effector cells in EAE as well as MS [10, 11].
However, their relevance was challenged by the observations that
mice deficient in IL-12, the IL-12 receptor, or IFN-γ are highly sus-
ceptible to EAE [12–14]. The notion that EAE is IL-23-dependent
and IL-12-independent is primarily based on experiments in which
mice on a C57BL/6 background were actively immunized with a
peptide ofmyelin oligodendrocyte glycoprotein (MOG35-55) in CFA
and injected with Bordetella pertussis toxin [5]. We questioned
whether a nonredundant role of IL-23 is specific for that model.
In fact, we and others have shown that, in certain adoptive
transfer paradigms, stimulation of ordinarily innocuous myelin-
specific CD4+ T cells with recombinant IL-12 is sufficient to con-
fer encephalitogenicity [2, 3, 15]. IL-12-polarized donor T cells
employed in those studies were derived from myelin-primed wild-
type mice. This led some to speculate that disease was mediated
by plastic Th17 cells that had been exposed to endogenous
IL-23 in vivo and subsequently acquired Th1 characteristics dur-
ing stimulation with IL-12 in vitro (so-called exTh17 cells) [16],
rather than by classic Th1 cells. Fate mapping studies have shown
that the majority of CD4+ T cells that infiltrate the CNS of MOG-
immunized C57BL/6 mice at peak EAE are exTh17 cells [17]. The
goal of the current study was to determine whether classical Th1
cells, that have not been exposed to IL-23 signaling, are capable
of mediating inflammatory demyelination.
Results and discussion
Th1 cells and Th17 cells differentiate independent
of IL-23 and IL-12, respectively
IL-12 and IL-23 are heterodimers composed of a common IL-12p40
chain and a unique IL-12p35 or IL-23p19 chain, respectively. We
immunized C57BL/6 mice deficient in the IL-12p40 chain (and
therefore unable to produce either bioactive IL-12 or IL-23) with
MOG35-55 emulsified in CFA. In order to generate pure popula-
tions of Th1 and Th17 cells, draining lymph node cells (LNC)
were obtained 10 days later and challenged ex vivo with anti-
gen plus either recombinant IL-12 and IFN-γ, or IL-23, IL-1α,
and anti-IFN-γ, respectively. As expected, a significant percentage
of IL-12-polarized IL-12p40−/− Th1 cells produced IFN-γ but not
IL-17, while the converse was true of their IL-23-polarized Th17
counterparts (Fig. 1A). Th1 cells expressed high levels of tbx21,
while Th17 cells expressed high levels of rorc (Fig. 1B). Relatively
few Th1 cells produced GM-CSF compared with Th17 cells derived
from the same IL-12p40−/− donor pool (Fig. 1A). However, IL-12
can suppress GM-CSF production by murine Th1 cells [8]. We
questioned whether committed Th1 cells would upregulate GM-
CSF upon reactivation in the absence of IL-12. Indeed, a
high percentage of Th1 cells, derived from either IL-12p40−/−
or WT donors, expressed GM-CSF during secondary anti-
genic challenge in vitro under neutral conditions (Fig. 1C).
The reactivated Th1 cells expressed a high IFN-γ/low IL-17
profile, irrespective of donor phenotype. IL-23-polarized
T cells derived from IL-12p40−/−, but not from WT, donors main-
tained a high level of IL-17 and low level of IFN-γ production dur-
ing in vitro reactivation, indicating that they had not converted
into exTh17 cells (Fig. 1C and D). Similar results were obtained
in parallel experiments with Th1 and Th17 cells derived from
donors deficient in the IL-23 receptor (IL-23R) or IL-12 receptor
(IL-12Rβ2), respectively (Fig. 1D–G). IL-23-independent, IL-12-
polarized CD4+ T cells express negligible levels of rorc during
polarizing culture, consistent with a classical Th1 phenotype and
not an exTh17 phenotype (Supporting Information Fig. 1).
Th1 cells can induce EAE independent of IL-23
Next, we assessed the ability of highly polarized Th1 cells to induce
EAE by an IL-23-independent pathway. Thakker et al. previously
demonstrated that Th1 cells derived from IL-23-deficient donors
are encephalitogenic in wild-type hosts [18]; however, this study
does not rule out the possibility that host-derived IL-23 rescues
T-cell encephalitogenicity following transfer. In order to eliminate
IL-23 at all stages of disease, MOG-primed T cells derived from
IL-12p40−/− mice were polarized with recombinant IL-12 and
injected into IL-12p40−/− hosts. For controls, some T cells from the
same donor pool were cultured in the presence of IL-23, or in the
absence of any recombinant cytokines, prior to adoptive transfer
into other groups of IL-12p40-/- mice. The IL-12-polarized cells
reproducibly induced EAE in 100% of recipients, with an accel-
erated and more severe course than the disease induced by their
IL-23-polarized counterparts (Fig. 2A). T cells cultured under neu-
tral conditions failed to induce clinical EAE in any of the recipients
(Supporting Information Fig. 2). Consistent with these results,
IL-12-polarized, MOG-specific IL-23R−/− T cells transferred clini-
cal EAE toWT recipients at high incidence (Fig. 2D). In both exper-
imental systems, donor Th1 cells continued to produce IFN-γ,
but little IL-17, after infiltrating the CNS (Fig. 2B, C, E, and F).
They also produced GM-CSF, reminiscent of Th1 cells reactivated
under neutral conditions in vitro (Fig. 1C). These data demon-
strate that classical Th1 cells, bereft of IL-23 signaling during the
priming, expansion, and effector stages, are potent encephalito-
genic effectors. To our knowledge, this is the first report of EAE
induction in the complete absence of IL-23.
IL-23-polarized T cells derived from IL-12p40−/− or
IL-12Rβ2−/− donors expressed a high ratio of IL-17 to IFN-γ
in the CNS of IL-12p40−/− and WT recipients, respectively,
demonstrating that the majority of transferred cells had retained
a Th17 phenotype yet were still capable of mediating clinical
EAE (Fig. 2B, C, E, and F). Interestingly, most IL-12Rβ2−/−
donor T cells did not transition to an exTh17 phenotype in
WT hosts, despite their accessibility to IL-23 signaling. This
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Figure 1. IL-12 and IL-23 promote the differentiation of stable Th1 and Th17 cells, respectively, in the absence of the reciprocal polarizing factor.
(A–D) LNC were harvested from IL-12p40−/− mice 10 days following immunization with MOG35-55 in CFA. Cells were cultured with antigen plus
IL-12 and IFN-γ (Th1) or IL-23, IL-1α, and anti-IFN-γ (Th17). Cells were harvested 4 days later for flow cytometric analysis and RNA extraction.
(A) Cytokine expression in CD4+CD44+ T cells following 4 h of stimulation with PMA/Ionomycin ex vivo was determined by flow cytometry.
(B) Transcription factor expression in purified CD4+ T cells, measured by quantitative RT-PCR and normalized to gapdh. (C, D) CD4+
T cells were purified from Th-polarized IL-12p40−/− or WT primary cultures, washed, rested for 2 days, and re-challenged with anti-
gen and T-depleted IL-12p40-/- or WT splenocytes, respectively, under neutral conditions. CD4+CD44+ T cells were analyzed for cytokine
expression at 24 h by flow cytometry. The bar graph represents biological replicates; n = 3 per group. (E–G) LNC were harvested from
MOG/CFA-immunized IL-23R−/− or IL-12Rβ2−/- mice and cultured with antigen under Th1 or Th17 polarizing conditions, respectively, for
4 days. (E) Cytokine expression in PMA/Ionomycin-stimulated CD4+CD44+ T cells was analyzed by flow cytometry. (F) Transcription fac-
tor levels in purified CD4+ T cells were measured by quantitative RT-PCR as described above. (G) MOG-specific cytokine production
in CD4+CD44+ T cells following rest and re-challenge with WT T-depleted splenocytes, as analyzed by flow cytometry. Data are rep-
resentative of at least 10 (A,E), or 2–4 (B,C,D,F,G) independent experiments with n3 mice per group. (B, D, F) Data are shown as
mean ± SEM. *p0.05, **p0.01, ***p0.001 using the two-tailed, unpaired t-test.
finding is consistent with previous reports of EAE mediated by
IL-23-polarized, T-bet-deficient CD4+ T cells, which also retain
a polarized Th17 phenotype post-transfer, and suggests that
IL-12 might play a distinctive role driving Th17 plasticity in
vivo [19–21].
IL-23-independent Th1 cells induce cytokine
production and monocyte-rich infiltrates in the CNS
We next interrogated the characteristics of CNS infiltrates and
the cytokine/chemokine profile induced by Th1 cells in our
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Figure 2. IL-12-polarized T cells induce EAE independent of IL-23 signaling. (A–C) LNC from MOG/CFA-immunized CD45.2+ IL-12p40−/− mice were
cultured for 4 days with antigen under Th1 or Th17 polarizing conditions. Purified CD4+ T cells were adoptively transferred into naı¨ve CD45.1+
IL-12p40−/− hosts. (A) Mean clinical scores; n = 6–7 mice per group, from one of four experiments with similar results. (B, C) At peak disease,
leukocytes were recovered from the spinal cord, and stimulated with PMA/Ionomycin ex vivo. The figures show cytokine expression in CD45.2+
CD4+ donor T cells as determined by flow cytometry. (D–F) MOG35-55-reactive CD4+ IL-23R−/− Th1 or IL-12Rβ2−/− Th17 cells were purified and
adoptively transferred into naive CD45.1+ WT hosts. (D) Mean clinical scores; n = 6 mice per group, from one of three independent experiments
with consistent results. (E,F) At peak disease, leukocytes were recovered from the spinal cord, and stimulated with PMA/Ionomycin ex vivo. The
figures show cytokine expression in CD45.2+ CD4+donor T cells as determined by flow cytometry. (B, C, E, F) Data are representative of two
independent experiments with n3 mice per group. Bar graphs represent biological replicates. Data in A, C, D, F are shown as mean ± SEM.
*p0.05, **p0.01, ***p0.001 using the two-tailed, unpaired t-test.
IL-23-independent EAE models. CNS tissues obtained from mice
injected with IL-12-independent Th17 cells were analyzed as a foil.
As in conventional models of EAE, inflammation was concentrated
in the thoracolumbar spinal cord of both Th1 and Th17 recipients
(Fig. 3A). The percent of MHC Class II+ monocytes and myeloid
dendritic cells tended to be higher in infiltrates induced by IL-23-
independent Th1 cells compared with stable Th17 cells (Fig. 3B).
Th1 cells induced elevated levels of CCL2 in CNS homogenates, as
well as other myeloid-related factors including TNF-α, GM-CSF,
IL-6, and IL-1α (Fig. 3C). Such an inflammatory milieu is likely
to favor the recruitment of monocytes. CCR2−/− mice were rela-
tively resistant to EAE following the transfer of either IL-23R−/−
Th1 or IL-12Rβ2−/− Th17 donor cells, signifying a damaging role
of inflammatory monocytes in both forms of EAE (Fig. 3D).
IFN-γ has been reported to have both protective and pathogenic
effects in inflammatory demyelination [13, 22, 23]. The role of
IFN-γ in IL-23-independent EAE has yet to be determined. We
found that neutralization of IFN-γ did not suppress EAE induc-
tion by IL-23-independent Th1 cells (data not shown). These data
contribute to a growing body of data demonstrating the dispens-
ability of individual “hallmark” cytokines in autoimmune disease
[6, 13].Similarly, iNOS was highly upregulated in Th1 recipients,
yet iNOS−/− mice remained highly susceptible to Th1-mediated,
IL-23-independent EAE (data not shown).
Concluding remarks
The current study challenges the dogma that IL-23 is universally
critical for the development of EAE. Collectively, our data sub-
stantiate and expand previous studies indicating that clinically
similar forms of EAE may be mediated by distinct autoreactive T-
cell subsets via parallel inflammatory pathways, in a more defini-
tive manner than previously shown [23, 24]. If these findings are
translatable to human autoimmune disease, they suggest that the
therapeutic targeting of proximal factors that promote the differ-
entiation and/or stabilization of encephalitogenic T cells should be
customized based on the predominant Th subset in an individual’s
autoreactive repertoire. Conversely, we found that CNS GM-CSF
production and monocyte recruitment are common features of
EAE initiated by disparate effector T cells. Hence, targeting innate
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Figure 3. EAE mediated by IL-23-independent Th1 cells is characterized by monocyte-rich infiltrates and is partially CCR2-dependent. (A–C) EAE
was induced by adoptive transfer of MOG35-55-reactive IL-12p40−/− Th1 or Th17 cells. (A) Upon reaching a score of 2, mice were perfused and spinal
cords isolated for immunohistochemistry. Sections of the lumbar spinal cord were stained for DAPI (blue), myelin basic protein (MBP, green),
and CD45 (white) and analyzed by confocal microscopy. Scale bar = 200 μm. (B) At disease onset, leukocytes were isolated from the spinal cord,
and the frequencies of MHC-II+ monocytes (CD11b+CD11c−Ly6G−) and dendritic cells (CD11b+CD11c+) were determined by flow cytometry. n =
3 mice per group, from one of two independent experiments. Mice from each group were matched based on clinical score. The gating strategy
is shown in Supporting Information Fig. 3. (C) Spinal cords were isolated at disease onset, homogenized, and centrifuged to pellet the tissue.
Supernatants were subjected to a multiplex bead assay. Data were pooled from two independent experiments with six to seven mice per group.
(D) MOG35-55-reactive IL-23R−/− Th1 cells or IL-12Rβ2−/− Th17 cells were transferred into naı¨ve syngeneic CCR2−/− or WT hosts. n = 4–7 mice per
group, from one of three independent experiments with consistent results. Data in B–D are shown as mean ± SEM. *p0.05, **p0.01, ***p0.001
using the two-tailed, unpaired t-test (B, C). Clinic courses were compared using 2-way ANOVA, *p as indicated (C).
immune cells or factors that regulate them might have broader
therapeutic efficacy.
Materials and methods
Mice
C57BL/6 WT and CD45.1 congenic mice were obtained from
Charles River Laboratories (Wilmington, MA, USA). C57BL/6
IL-12Rβ2−/−, iNOS−/−, CCR2−/−, and IFN-γR−/− mice were
obtained from Jackson Labs (Bar Harbor, ME, USA). IL-23R−/−
were the generous gift of Dr. Nico Ghilardi (Genentech, South
San Francisco, CA, USA) [4]. IL-12p40−/− mice were originally
obtained from J. Magram (Hoffman LaRoche, Nutley, NJ, USA)
[25]. All mice were bred and maintained under specific pathogen-
free conditions in the University of Michigan animal housing facil-
ities. All protocols were approved by the University of Michigan
Committee on Use and Care of Animals.
Immunization and cell culture
Mice were subcutaneously immunized with an emulsion of com-
plete Freund’s adjuvant (CFA; Difco, Detroit, MI, USA) and 100 μg
of myelin oligodendrocyte glycoprotein peptide 35–55 (Biosynthe-
sis, Lewisville, TX, USA). Draining lymph nodes were harvested
and homogenized into a single cell suspension 10–14 days later.
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Cells were cultured for 96 h in the presence of MOG35-55 at
50 μg/ml and either Th1- or Th17-polarizing factors, as previ-
ously described [2, 20]. For rest and rechallenge experiments,
in vitro polarized CD4+ T cells were purified by magnetic acti-
vated cell-sorting (MACS) (Miltenyi Biotech, San Diego, CA, USA),
and rested for 48 h without exogenous cytokines. On the day
of rechallenge, CD4+ T cells were harvested and co-cultured
with T-depleted splenocytes (prepared using anti-CD4 MACS
microbeads) in the presence or absence of MOG35-55 at 50 μg/ml.
Quantitative PCR
RNA was isolated from purified CD4+ T cells using TRIzol Reagent
(Life Technologies, Grand Island, NY, USA) and converted into
cDNA using the High Capacity cDNA Reverse Transcription Kit
(Life Technologies). qPCR was performed on an iQ Thermocycler
(Bio-Rad, Hercules, CA, USA) with predesigned Taqman assays
(Life Technologies).
Induction of EAE
Na¨ıve C57BL/6 WT or IL-12p40−/− mice were injected with 3–5
× 106 CD4+ T cells isolated from MOG-reactive Th cultures. Mice
were rated on a daily basis by an examiner blinded to experimental
groups according to the following scale: (i), limp tail; (ii), hind-
limb weakness; (iii), partial hind-limb paralysis; (iv), complete
paralysis of hind-limbs; and (v), moribund state.
Isolation of CNS mononuclear cells
Mice were perfused with PBS via the intracardiac route. CNS tis-
sues were homogenized in the presence of protease inhibitors
using an 18G needle and syringe and centrifuged to pellet the
tissue. Supernatants were collected and stored. The pellet was
digested in a solution of collagenase A (1 mg/mL, Roche, Indi-
anapolis, IN, USA) and DNase1 (1 mg/mL, Sigma-Aldrich, St.
Louis, MO, USA). Mononuclear cells were enriched on a 30%/70%
Percoll gradient (GE Healthcare, Pittsburgh, PA, USA).
Flow cytometry
CNS mononuclear cells and cultured Th cells were stimulated
with PMA (50 ng/mL) and ionomycin (2 μg/mL) in the pres-
ence of brefeldin A (10 μg/mL) for 4 h. For rest and rechallenge
experiments, brefeldin A (10 ug/ml) was added for the final 4 h
of culture. For intracellular staining, cells were fixed with 4%
paraformadehyde and permeabilized with 0.5% saponin. Fluores-
cent antibodies were purchased from eBioscience (San Diego, CA,
USA) and BD Biosciences (San Jose, CA, USA). Data were acquired
using an FACSCanto II flow cytometer (BD Biosciences) and ana-
lyzed using FlowJo software (Treestar, Ashland, OR, USA).
Multiplex immunoassays
Supernatants of homogenized CNS tissues were analyzed
with a customized Milliplex Mouse Cytokine/Chemokine Kit
(MPXMCYTO-70K, Millipore, Billerica, MA, USA) using the Bio-
Plex 200 System (Bio-Rad). Cytokine and chemokine levels were
normalized to total protein as quantified by Bradford assay.
Immunofluorescence
Mice were perfused with Tyrode’s solution followed by 4%
paraformaldehyde in PBS. The spinal column was removed, post-
fixed, decalcified, cryoprotected, embedded, and frozen in OCT
(Cellpath, Newton, UK). Twelvemicrometer sections were blocked
with Avidin D and biotin (Vector Labs, Burlingame, CA, USA),
and stained with the following primary and secondary antibod-
ies: goat anti-MBP (1:300, Millipore), Alexa Fluor 488-conjugated
rabbit anti-goat IgG (1:300, Life Technologies), biotinylated rat
anti-CD45 (1:100, eBioscience), and Alexa Fluor 647-conjugated
streptavidin (1:300, Life Technologies). Nuclei were labeled with
DAPI (Life Technologies). Images were acquired on a Nikon A1
confocal microscope (Nikon, Tokyo, Japan).
Statistics
Immune parameters were compared using the unpaired Student’s
t-test with Prism 6 software (GraphPad, La Jolla, CA, USA). Clini-
cal scores were compared by two-way ANOVA. p values: *<0.05,
**<0.01, ***<0.001.
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